Loading clinical trials...
Loading clinical trials...
Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer
Conditions
Interventions
VERU-100
Locations
11
United States
Arizona Urology Specialist
Tucson, Arizona, United States
Urology Associates of Southern Arizona
Tucson, Arizona, United States
San Bernardino Urological Associates
San Bernardino, California, United States
Genesis Research, LLC
San Diego, California, United States
Debbie Urology Johnson
Jeffersonville, Indiana, United States
Chesapeake Urology Research Associates
Towson, Maryland, United States
Start Date
June 9, 2021
Primary Completion Date
January 19, 2023
Completion Date
January 19, 2023
Last Updated
May 19, 2023
NCT06173362
NCT02893917
Lead Sponsor
Veru Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions